Search

Compugen Ltd

Abierto

2.1 1.94

Resumen

Variación precio

24h

Actual

Mínimo

2.02

Máximo

2.14

Métricas clave

By Trading Economics

Ingresos

663K

-7M

Ventas

426K

2.6M

P/B

Media del Sector

5.211

51.78

BPA

-0.07

Margen de beneficios

-269.254

Empleados

75

EBITDA

665K

-7M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+129.59% upside

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-38M

188M

Apertura anterior

0.16

Cierre anterior

2.1

Compugen Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

9 nov 2026, 23:56 UTC

Morningstar, Inc. is showing little change in after-market trading, having peaked at a modest increase after starting the session down significantly.

9 nov 2026, 23:56 UTC

National Healthcare Corp is advancing in after-market trading, significantly above the lower end of its one-month trading range since Monday's close.

9 nov 2026, 23:56 UTC

Globus Medical, Inc. is trading lower in after-market hours, continuing a downward trend from Monday's close and near the lower end of its one-month range.

9 nov 2026, 23:56 UTC

McCormick & Company shares advanced modestly higher in after-market hours, rebounding from an initial dip to close at the higher end of its recent range.

9 nov 2026, 23:56 UTC

Powell Industries Inc is trading modestly higher in after-market hours, recovering from a significant dip earlier in the session.

9 nov 2026, 23:56 UTC

Correlated Moves

ONEOK Inc. shares advanced modestly in after-market hours, influenced by a higher move in Kinetik Holdings Inc., which has a historical correlation with ONEOK.

9 nov 2026, 23:56 UTC

Wendy's Co shares are trading higher in after-market hours, maintaining a level just above Monday's close amid a strong broader market context.

9 nov 2026, 23:56 UTC

Event

Allogene Therapeutics announces preliminary safety and efficacy data from its Phase 1 RESOLUTION study for ALLO-329, an investigational CAR T product.

9 nov 2026, 23:52 UTC

Carlisle Companies Incorporated shares are trading lower in after-market hours, shifting from a slight gain to a notable loss.

9 nov 2026, 23:51 UTC

Franklin Street Properties Corp is trading sharply higher in after-market hours, reaching a notable peak after starting flat following Monday's close.

9 nov 2026, 23:51 UTC

Howmet Aerospace Inc. is advancing in after-market trading, supported by stronger-than-expected U.S. wholesale inventories and cautious Federal Reserve remarks on monetary policy.

9 nov 2026, 23:51 UTC

NIO Inc. has seen modest gains in after-market trading, rising steadily and positioning the stock above its 20-day moving average.

9 nov 2026, 23:51 UTC

Schrodinger Inc shares are trading modestly lower in after-market hours, following a notable dip shortly after the regular session ended.

9 nov 2026, 23:51 UTC

Organon & Co. shares are trading modestly lower during after-market hours, positioned near the lower end of their one-month trading range amid ongoing performance weakness.

9 nov 2026, 23:51 UTC

News

Jefferies maintains a Buy rating on Airbnb, Inc. and raises its price target to $230, citing confidence in the company's growth prospects.

9 nov 2026, 23:51 UTC

Primerica, Inc. has gained modestly in after-market trading, reaching its highest cumulative return since Monday's close with strong momentum and five consecutive higher daily closes.

9 nov 2026, 23:51 UTC

UK Retail Sales Monitor YoY for October 2026 Expected to Show Modest Growth Amid Economic Caution and Inflationary Pressures

9 nov 2026, 23:51 UTC

Japan's Household Spending Plummets 2.8% in September, Sparking Concerns Over Economic Health and Consumer Confidence

9 nov 2026, 23:51 UTC

Australia's Westpac Consumer Confidence Index drops to 82.6, signaling continued decline in consumer sentiment amid economic uncertainties.

9 nov 2026, 23:51 UTC

Japan's household spending plunges 6.8% YoY in September, worse than expected, sparking a 3.2% rise in Nikkei futures amid ongoing economic concerns.

9 nov 2026, 23:51 UTC

Australia's Consumer Confidence Rises 2.7% Amid Ongoing Economic Concerns, Yet Sentiment Remains Fragile

9 nov 2026, 23:51 UTC

News

EVI Industries reports Q1 earnings of $0.24 per share, exceeding estimates, with revenue of $112.948 million and a 108% increase in net income to $3.847 million.

9 nov 2026, 23:51 UTC

Fluor Corp shares are declining in after-market trading, pulling back from a brief peak shortly after the market closed.

9 nov 2026, 23:51 UTC

Archer-Daniels-Midland Co is trading modestly higher in after-market hours, having shown notable strength earlier in the session.

9 nov 2026, 23:51 UTC

News
Event

Mesa Laboratories reports Q2 net income of $4.34 million, revenue of $62.34 million, and projects full-year revenue of $250M to $255M.

9 nov 2026, 23:51 UTC

Aquestive Therapeutics, Inc. shares are rising in after-market hours, supported by positive U.S. wholesale inventory data and easing geopolitical tensions affecting crude oil prices.

9 nov 2026, 23:51 UTC

Kimberly-Clark Corporation shares declined in after-market trading, reversing earlier gains and remaining modestly lower compared to Monday's close.

9 nov 2026, 23:51 UTC

Walt Disney Company shares are modestly lower in after-market hours, following a notable decline from earlier highs reached shortly after the market closed.

9 nov 2026, 23:51 UTC

Correlated Moves

TTM Technologies Inc shares are higher in after-market trading, following a notable rise in Sanmina Corporation after it reported strong fourth-quarter results.

9 nov 2026, 23:51 UTC

Social Media

Children's Place Inc shares fell sharply in after-market hours following news of its Chapter 11 bankruptcy filing and plans to seek bids by December 9.

Comparación entre iguales

Cambio de precio

Compugen Ltd previsión

Precio Objetivo

By TipRanks

129.59% repunte

Estimación a 12 Meses

Media 4.5 USD  129.59%

Máximo 6 USD

Mínimo 4 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

4

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat